ALDX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

ALDXAldeyra Therapeutics, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

ALDXAldeyra Therapeutics, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

ALDXAldeyra Therapeutics, Inc.

0.61▼−5.53%· post 0.61

Mkt cap$39.1MRevenue—Revenue—

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,363.77

ClosedNov 5 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 5 '26

ALDXAldeyra Therapeutics, Inc.

LLYELI Lilly & Co

0.61▼−5.53%post 0.61

Price

1,371.32▼−3.29%post 1,363.77

$39.1M

Mkt cap

$1.2T

—

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

ALDX0.61▼−5.53%vsLLY1,371.32▼−3.29%ClosedNov 5 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ALDX 2

ABBVAbbViecustomer

—Massachusetts Eye and Ear Infirmaryunlistedsupplier

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›